Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response”

3,804 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,804 results

Early research (Phase 1)Ended earlyNCT02317302
What this trial is testing

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Who this might be right for
Cervical CancerUterine Cervical CancerUterine Cervical Neoplasms
Washington University School of Medicine 48
Testing effectiveness (Phase 2)UnknownNCT00568607
What this trial is testing

Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma

Who this might be right for
Lymphoma
Fudan University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06620822
What this trial is testing

Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 296
Not applicableStudy completedNCT06235853
What this trial is testing

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerCystoscopyRecurrence+3 more
Wroclaw Medical University 240
Not applicableUnknownNCT04273477
What this trial is testing

Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Not applicableStudy completedNCT02827357
What this trial is testing

Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation

Who this might be right for
Lung Cancer
University Hospital, Toulouse 101
Not applicableStudy completedNCT01686412
What this trial is testing

Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated Frequency

Who this might be right for
Hepatocellular CarcinomaBreast Cancer
Hospital Sirio-Libanes 60
Not applicableUnknownNCT00449319
What this trial is testing

AML Treatment in Untreated Adult Patients

Who this might be right for
Leukemia, Myelocytic, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Early research (Phase 1)Study completedNCT00029900
What this trial is testing

ADI-PEG in Patients With Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
FDA Office of Orphan Products Development 15
Not applicableStudy completedNCT02859753
What this trial is testing

Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation

Who this might be right for
ThermoablationChronic Liver DiseaseHepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 35
Large-scale testing (Phase 3)Not Yet RecruitingNCT06724237
What this trial is testing

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more
Eastern Cooperative Oncology Group
Not applicableUnknownNCT03739177
What this trial is testing

Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients

Who this might be right for
Bladder Cancer
Animated Dynamics, Inc. 150
Large-scale testing (Phase 3)Study completedNCT06775652
What this trial is testing

Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Yongtao Han 254
Not applicableActive Not RecruitingNCT03343236
What this trial is testing

Nutrition and Inflammation in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsRadiotherapy Side EffectInflammation+1 more
Uppsala University 522
Not applicableUnknownNCT04150471
What this trial is testing

Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients

Who this might be right for
Chronic Myelocytic Leukemia
Seoul St. Mary's Hospital 79
Not applicableUnknownNCT05172063
What this trial is testing

Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness

Who this might be right for
Children With CancerSARS-CoV-2 Infection
Children's Cancer Hospital Egypt 57357 30
Not applicableNot Yet RecruitingNCT06839014
What this trial is testing

Exercise Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCC
Our Lady of the Lake Hospital 40
Not applicableStudy completedNCT00898014
What this trial is testing

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Institut Curie 216
Not applicableLooking for participantsNCT06863844
What this trial is testing

The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor

Who this might be right for
Urothelial Neoplasm
IRCCS Azienda Ospedaliero-Universitaria di Bologna 210
Not applicableUnknownNCT03548844
What this trial is testing

Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy

Who this might be right for
Rectal CancerSurgery
Yanhong Deng 326
Load More Results
294